U.S. market Closed. Opens in 1 day 6 hours 46 minutes

CRBU | Caribou Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue34.48M13.85M9.60M12.36M5.79M
Cost of Revenue112.08M3.64M984.00K34.42M23.64M
Gross Profit-77.60M10.21M8.61M-22.06M-17.85M
Operating Expenses150.54M120.25M76.58M48.48M40.09M
Selling, General & Admin38.46M38.02M24.32M14.06M16.46M
Research & Development112.08M82.23M52.26M34.42M23.64M
Other Operating ExpensesN/A7.18M-1.35M514.00KN/A
Operating Income-116.06M-106.40M-66.98M-36.12M-34.30M
Other Expenses / Income14.18M7.05M377.00K-3.00K3.34M
Before Tax Income-101.88M-99.35M-66.60M-36.13M-30.97M
Income Tax Expenses193.00K70.00K321.00K-1.82M-7.54M
Net Income-102.07M-99.42M-66.92M-34.31M-23.43M
Interest ExpensesN/AN/A8.00K20.00K4.00K
Basic Shares Outstanding73.81M60.80M60.26M59.97M59.97M
Diluted Shares Outstanding73.81M60.80M60.26M59.97M59.97M
EBITDA-112.53M-104.78M-66.00M-35.21M-30.21M
EBITDA Margin-326.40%-756.46%-687.59%-284.82%-521.99%
EBIT-101.88M-99.35M-66.59M-36.11M-30.96M
EBIT Margin-295.49%-717.28%-693.83%-292.10%-534.97%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙